Some researchers have also stated that the addition of one or more serum biomarkers to AFP, such as des-gamma-carboxy prothrombin (DCP), glypican-3 (GPC3), and Golgi protein 73 (GP73), does not significantly improve its diagnostic accuracy for HCC (48). The gene discussed is ACE; the disease is hepatocellular carcinoma.